Source: sec.gov

Auron received $27M in Series B Funding

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

Founder & CEO

Kate Yen

CEO Approval Rating

90/100

Auron is a Massachusetts-based biotechnology company that develops and commercializes therapies for the treatment of cancer.